API | oxyphencyclimine

oxyphencyclimine (daricon) Report issue

Small molecule Approved ^FDA

ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW

Oxyphencyclimine is an anticholinergic drug (trade name Daricon) used in treating peptic ulcers. Daricon was discontinued in USA, but still used worldwide. ^NCATS

Chemistry

SMILES: CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3
InChIKey: DUDKAZCAISNGQN-UHFFFAOYSA-N
Mol. Mass: 344.46
ALogP: 2.73 Partition coefficient
ChEMBL Molecules:

oxyphencyclimine

oxyphencyclimine hydrochloride

More Chemistry

Pharmacology

Mechanisms of Action:
- Muscarinic acetylcholine receptor M1 (Homo sapiens) ^UniProt
- Muscarinic acetylcholine receptor M3 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Discontinued
Delivery Methods: Oral
Pro Drug: No

Organizations (2)

Research & Development (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Peptic Ulcer

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue